Exploring the Anti‐Inflammatory Molecular Mechanism of Gentiana szechenyii Kanitz. Based on UPLC–MS/MS Combined With Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202502421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Xingqing Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Eco-Environmental Engineering of Qinghai University, Xining, P. R. China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Molecular Dynamics Simulation, Anti-Inflammatory Agents, Gentiana. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Key Research&Development and Transformation Programs of Qinghai Province, Qinghai Kunlun Talents Program.
Abstract (Originalsprache)
This study explored the anti‐inflammatory mechanisms of Gentiana szechenyii Kanitz. (GS), a Tibetan medicinal herb, by combining UPLC–MS/MS, network pharmacology, molecular docking, and molecular dynamics (MD) simulation. Using the lipopolysaccharide (LPS)‐induced RAW264.7 cell inflammation model, the anti‐inflammatory effect of GS was confirmed by detecting the release amount of nitric oxide (NO) and the levels of inflammatory factors tumor necrosis factor (TNF) and interleukin‐6 (IL‐6). UPLC–MS/MS identified 40 constituents, whereas network analysis predicted 5 core compounds (isovitexin 4′,7‐diglucoside, loganin, isoorientin‐2″‐ O ‐glucoside, gentiopicroside, sweroside), 5 key targets (TNF, IL‐6, GAPDH, epidermal growth factor receptor [EGFR], HSP90AA1), and three critical pathways (PI3K‐Akt, hypoxia inducible factor‐1 [HIF‐1], IL‐17). Molecular docking showed strong binding between core compounds and targets; the binding energies were all lower than −5 kcal mol −1 , among which isovitexin 4′,7‐diglucoside had the lowest binding energy to EGFR (−9.4 kcal mol −1 ). MD simulation confirmed stable binding of TNF with the five core compounds. This study comprehensively clarifies the pharmacodynamic material basis and mechanism of action of GS in anti‐inflammation, providing an experimental basis for further development and utilization. It is expected to be applied to the adjuvant treatment of inflammation‐related diseases such as chronic bronchitis and pharyngitis in the future, thereby promoting the modernization of Tibetan medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eco-Environmental Engineering of Qinghai University, Xining, P. R. China.
- Qinghai Provincial Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, P. R. China.
Förderung
- Key Research&Development and Transformation Programs of Qinghai Province
- Qinghai Kunlun Talents Program
Zitieren
APA
Liu, X., Wang, M., Wu, S., Wang, H., Tie, F., Hu, N., Zhou, W., & Dong, Q. (2026). Exploring the Anti‐Inflammatory Molecular Mechanism of Gentiana szechenyii Kanitz. Based on UPLC–MS/MS Combined With Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202502421
Vancouver
Liu X, Wang M, Wu S, Wang H, Tie F, Hu N, et al. Exploring the Anti‐Inflammatory Molecular Mechanism of Gentiana szechenyii Kanitz. Based on UPLC–MS/MS Combined With Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202502421
BibTeX
@article{Liu2026,
author = {Liu, Xingqing and Wang, Mengshu and Wu, Shengling and Wang, Honglun and Tie, Fangfang and Hu, Na and Zhou, Wu and Dong, Qi},
title = {Exploring the Anti‐Inflammatory Molecular Mechanism of Gentiana szechenyii Kanitz. Based on UPLC–MS/MS Combined With Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202502421}
}
EUVIMED